Patient tumor organoids were generated usingunsorted tumor cells with and without enrichment of patientimmune cells derived from peripheral blood, the spleen,or lymph nodes for therapy with PD-1 (programmed celldeath protein 1) inhibitors and T-cell activators. Here, PDCD1 is linked to neoplasm.